In patients with myocardial infarction, a significant increase in the serum level of RANTES was previously reported [53, 54], and the elevated serum levels of this marker are associated with a 2 to 3.4 times higher mortality risk in patients with acute coronary syndrome [55]. Here, CCL5 is linked to myocardial infarction.